Price $10.60 |
Market Cap
269.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.78
|
P/S
0.84
|
Dividend %
-
|
|
P/CF
27.2
|
P/FCF
-
|
Op. Cash Flow
19.3K
|
FCF
-1.5
|
|
Op. Margin
-4.20%
|
Net Margin
-6.50%
|
ROE
-12.60%
|
ROI
-1.20%
|
|
ROA
-5.00%
|
EPS Growth
-
|
Current Ratio
1.8
|
Debt/Equity
146.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $7.95 | - | - | 113.3M | Strong Buy |
| Digirad Corporation (DRAD) | $1.50 | - | 14.20% | 31.1M | Strong Buy |
| Tenet Healthcare Corp (THC) | $23.28 | - | - | 2.41B | Strong Buy |
| Depomed Inc (DEPO) | $6.63 | - | - | 415.3M | Strong Buy |
| Nephros, Inc. (NEPH) | $0.56 | - | - | 23.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
